Cold atmospheric plasma and silymarin nanoemulsion synergistically inhibits human melanoma tumorigenesis via targeting HGF/c-MET downstream pathway
Cell Communication and Signaling, pp. 1-14, 2019.
Recent studies claimed the important role of cold atmospheric plasma (CAP) with nanotechnology in cancer treatments. In this study, silymarin nanoemulsion (SN) was used along with air CAP as therapeutic agent to counter human melanoma. In this study, we examined the combined treatment of CAP and SN on G-361 human melanoma cells by evaluat...More
Full Text (Upload PDF)
PPT (Upload PPT)